Stockscreener 앱 받기
1.80%
시간 외 거래:
Mckesson Corp 주식(MCK)의 최신 뉴스
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term - Zacks Investment Research
If You Invested $1000 in McKesson a Decade Ago, This is How Much It'd Be Worth Now - Zacks Investment Research
McKesson (MCK) Extends Key Distribution Tie Through 2032 And Expands Pharmacy Role - Simply Wall Street
McKesson Corporation (MCK) Stock forecasts - Yahoo Finance Singapore
McKesson Corp. stock outperforms competitors on strong trading day - MarketWatch
How AI Adoption Could Supercharge McKesson (MCK) - Yahoo Finance Singapore
Here's Why McKesson (MCK) is a Strong Growth Stock - Zacks Investment Research
Here's Why McKesson (MCK) Fell More Than Broader Market - Zacks Investment Research
Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance
Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes" - Zacks Investment Research
What Is McKesson (MCK) Gaining From This $5.8 Billion Option Care Deal? - Yahoo Finance
Option Care stock surges on McKesson’s home-infusion bet - TheStreet
CD&R And McKesson To Acquire Option Care Health For $5.8 Billion - Pulse 2.0
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now? - Yahoo Finance
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now? - Zacks Investment Research
McKesson Plans $1.4 Billion Stake in $5.8 Billion Option Care Buyout - finchannel
McKesson, private equity firm buy home infusion company, Option Care Health - Managed Healthcare Executive
McKesson Just Put $32.05 Cash on America's Biggest Home Infusion Name - Money Morning
McKesson Corporation (MCK) Stock Forecasts - Yahoo Finance
Option Care Health (OPCH) Rockets as CD&R, McKesson Table 37% Premium Bid - Yahoo Finance
Why Option Care Health Stock Skyrocketed on Tuesday - The Motley Fool
McKesson, CD&R to Buy Option Care Health in $5.8 Billion Deal - Yahoo Finance
McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal - Reuters
CD&R, McKesson acquiring infusion therapy provider Option Care Health for $5.8B - Fierce Healthcare
McKesson, CD&R to buy Option Care Health for $5.8 billion - Modern Healthcare
Option Care Health Agrees to $5.8 Billion Acquisition by CD&R and McKesson at $32.05 Per Share - Yahoo Finance
McKesson Buys Home Infusion Company Option Care for $5.8B - HomeCare
McKesson, CD&R to Buy Option Care in $5.8 Billion Deal - Bloomberg.com
Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
CD&R, McKesson to Acquire At-Home Infusion Therapy Provider for $5.8 Billion - WSJ
CD&R, McKesson Corporation sign agreement to acquire Option Care Health - MLex
OPCH shares jump 34% as CD&R, McKesson agree to $5.8B takeover (OPCH:NASDAQ) - Seeking Alpha
Cd&R And Mckesson Corporation Sign Agreement To Acquire Option Care Health - TradingView
McKesson, CD&R to Buy Option Care Health in $5.8 Billion Deal - Yahoo Finance
CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health - Yahoo Finance
McKesson, CD&R near $5 billion-plus deal to buy Option Care, FT reports - Yahoo Finance
Option Care Jumps on Report McKesson Is Preparing an Offer - Bloomberg.com
McKesson and CD&R strike $5.8bn deal to buy infusion services provider - Financial Times
Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex - Zacks Investment Research
Company News for Oct 2, 2026 - Zacks Investment Research
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve - Zacks Investment Research
McKesson (MCK) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Zacks Investment Research
Here's Why You Should Retain McKesson Stock in Your Portfolio for Now - Zacks Investment Research
McKesson stock falls 1.19 percent as targets split - AD HOC NEWS
McKesson Corp. stock outperforms competitors despite losses on the day - MarketWatch
McKesson (MCK) Lifted Its Guidance, Is The Stock Still 11% Undervalued? - finance.yahoo.com
McKesson (MCK) Stock Forecast and Price Target 2026 $MCK - MarketBeat
McKesson stock heads into the open after a 0.1 percent gain - AD HOC NEWS
McKesson Corp. stock underperforms Thursday when compared to competitors - MarketWatch
McKesson 5-year return hits 34.23%, beating market by 22.21% - scanx.trade
0.37%
자본화:
|
볼륨(24시간):